Rite Aid (RAD) Given Daily Media Impact Score of 0.13

News stories about Rite Aid (NYSE:RAD) have trended somewhat positive on Monday, according to Accern Sentiment. The research group rates the sentiment of news coverage by monitoring more than 20 million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Rite Aid earned a media sentiment score of 0.13 on Accern’s scale. Accern also assigned headlines about the company an impact score of 45.9450413413773 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the next few days.

These are some of the news headlines that may have impacted Accern Sentiment Analysis’s scoring:

How to Become a New Pot Stock Millionaire

Rite Aid stock opened at $1.68 on Monday. The company has a market cap of $1,740.26, a P/E ratio of -84.00 and a beta of 1.80. The company has a current ratio of 1.37, a quick ratio of 0.59 and a debt-to-equity ratio of 2.11. Rite Aid has a one year low of $1.38 and a one year high of $4.61.

Rite Aid (NYSE:RAD) last released its quarterly earnings results on Thursday, April 12th. The company reported ($0.01) EPS for the quarter, topping the consensus estimate of ($0.02) by $0.01. The firm had revenue of $5.39 billion for the quarter, compared to analyst estimates of $5.75 billion. Rite Aid had a negative return on equity of 8.25% and a net margin of 3.60%. The firm’s revenue for the quarter was down 8.6% compared to the same quarter last year. sell-side analysts expect that Rite Aid will post 0.04 EPS for the current year.

RAD has been the topic of several research analyst reports. Evercore ISI initiated coverage on Rite Aid in a research note on Thursday, January 4th. They issued an “underperform” rating and a $1.50 price objective on the stock. Zacks Investment Research lowered Rite Aid from a “hold” rating to a “sell” rating in a research report on Tuesday, January 9th. Finally, Vetr lowered Rite Aid from a “strong-buy” rating to a “buy” rating and set a $2.47 price target on the stock. in a research report on Thursday, January 11th. Two equities research analysts have rated the stock with a sell rating, six have given a hold rating, one has given a buy rating and one has assigned a strong buy rating to the company’s stock. The company currently has a consensus rating of “Hold” and an average price target of $2.33.

ILLEGAL ACTIVITY WARNING: “Rite Aid (RAD) Given Daily Media Impact Score of 0.13” was first published by Chaffey Breeze and is the property of of Chaffey Breeze. If you are accessing this article on another publication, it was illegally stolen and reposted in violation of United States & international trademark & copyright legislation. The correct version of this article can be read at https://www.chaffeybreeze.com/2018/04/16/rite-aid-rad-given-daily-media-impact-score-of-0-13.html.

About Rite Aid

Rite Aid Corporation, through its subsidiaries, operates a chain of retail drugstores in the United States. The company operates through Retail Pharmacy and Pharmacy Services segments. The Retail Pharmacy segment sells prescription drugs; and a range of other merchandise, such as over-the-counter medications, health and beauty aids, personal care items, cosmetics, household items, food and beverages, greeting cards, seasonal merchandise, and other everyday and convenience products.

Insider Buying and Selling by Quarter for Rite Aid (NYSE:RAD)

Receive News & Ratings for Rite Aid Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rite Aid and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply